COVID-19: Are there clinical trial data to support a homologous vaccine booster?
This means those who have received Covishield as their first and second dose will receive Covishield as their third dose.
Read More
Day: January 9, 2022
Conflicting signals from drug regulator, COVID-19 national task force
“Considering the emergency and unmet medical need in Covid-19, the SEC on December 27 recommended for grant of permission to
Read More
COVID-19: Even if mild, Omicron variant can overwhelming health-care settings
Huge percentage of the population in India got infected when the Delta variant raged through the country. Studies from other
Read More